Patent: 4,251,510
✉ Email this page to a colleague
Summary for Patent: 4,251,510
Title: | Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production |
Abstract: | Plasma Protein Fraction substantially free of bradykinin, kininogen and prekallikrein activators is obtained by treating Cohn Supernatant II plus III at about neutrality with a siliceous substance for a period of time sufficient to bring about essentially complete conversion of intrinsic kininogen into bradykinin. Subsequently, after being separated from Cohn Fraction IV-1, the Plasma Protein Fraction is reconstituted and held for a period of time sufficient to allow substantially complete destruction of bradykinin by kininase. Methods are disclosed for the destruction of prekallikrein activators which may be present in Plasma Protein Fraction. |
Inventor(s): | Tankersley; Donald L. (Rockville, MD) |
Assignee: | Cutter Laboratories, Inc. (Berkeley, CA) |
Application Number: | 06/066,757 |
Patent Claims: | see list of patent claims |
Details for Patent 4,251,510
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | PLASMANATE | plasma protein fraction (human) | Injection | 101140 | 10/02/1958 | ⤷ Try a Trial | 1998-02-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |